mesalamine has been researched along with Psychoses in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Excerpt | Relevance | Reference |
---|---|---|
"Thalidomide was discontinued and orally administered mesalazine was restarted." | 1.51 | Early onset first-episode psychosis during treatment with thalidomide for refractory ulcerative colitis: a case report. ( Ivagnes, S; Margari, F; Margari, L; Palumbi, R; Petruzzelli, MG, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Petruzzelli, MG | 1 |
Margari, L | 1 |
Ivagnes, S | 1 |
Palumbi, R | 1 |
Margari, F | 1 |
1 other study available for mesalamine and Psychoses
Article | Year |
---|---|
Early onset first-episode psychosis during treatment with thalidomide for refractory ulcerative colitis: a case report.
Topics: Adolescent; Aftercare; Age of Onset; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; | 2019 |